From: Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma
Case | Gender | Age ranges | Smoking status | Tumor location | Tumor size | Histology | Treatment | Stage | Follow up (status) |
---|---|---|---|---|---|---|---|---|---|
1 | Male | 35–40 (years) | no | right lower lobe peripheral | 4.0 cm | mixed low-grade and high-grade fetal lung adenocarcinoma in epithelial component and primitive mesenchymal | lobectomy and lymph node dissection adjuvant three cycles of chemotherapy | T2aN0M0 IB | 73 months (survival) |
2 | Male | 75–80 (years) | 50 packs/year | right upper lobe peripheral | 4.2 cm | pure high-grade fetal lung adenocarcinoma and primitive mesenchymal | lobectomy and lymph node dissection | T2bN0M0 IIA | 68 months (dead) |
3 | Female | 50–55 (years) | no | left lower lobe peripheral | 3.9 cm | pure high-grade fetal lung adenocarcinoma and primitive mesenchymal | chemotherapy followed by lobectomy and lymph node dissection | T2aN0M0 IB | 13 months (survival) |